Infectious complications of tumor necrosis factor-alpha antagonists

Int J Dermatol. 2005 Jun;44(6):443-8. doi: 10.1111/j.1365-4632.2004.02571.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Bacterial Infections / chemically induced*
  • Etanercept
  • Histoplasmosis / chemically induced*
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunosuppressive Agents / adverse effects*
  • Infliximab
  • Opportunistic Infections / chemically induced*
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
  • Etanercept